Articles

Find an Article

Filter articles

Showing 641 to 650 of 654 results

The role of the function of DNA sequence before and after grant

01-05-2011Caroline Pallard and Bart Swinkels

Recent European decisions have provided much to think about for practitioners concerned with DNA sequences. Caroline Pallard and Bart Swinkels investigate.

The Brazilian pharmaceutical sector: a year in review

Brazil01-05-2011Otto Licks and Anderson Nascimento

Practitioners can take heart from recent developments in the Brazilian courts, say Otto Licks and Anderson Nascimento.

Patentability of dosage regimens in Europe

France01-05-2011Stéphane Agasse

First instance courts in France have adopted controversial interpretations of an important Enlarged Board of Appeal decision, says Stéphane Agasse.

A revolution: biotech patents in India

India01-05-2011Archana Shanker

It has taken a long time for India to develop a productive environment for biotechnology. But recent developments look to have put it on the right track. Archana Shanker explains.

Recognising equivalence, reciprocity and respect

Canada, Mexico, US01-05-2011Hedwig Lindner and Manuel Morante

Homologation (recognition of equivalence) is a useful tool for simplifying administrative processes that are repeated in different countries. Nevertheless, it is not an end in itself.

Banning the patenting of biological materials in Australia: fact v fiction

Australia01-05-2011Tania Obranovich

An Australian legislative bill could have grave consequences for the country’s life sciences industry and, potentially, for patients as well. Tania Obranovich explains.

Windows of opportunity and closing doors at the EPO

EU01-05-2011Claire Baldock

There is a general acceptance that European patent law is complicated, particularly in the area of pharmaceutical inventions. Claire Baldock looks at how the EPO approaches these inventions.

Patenting life

EU01-05-2011Ashley Roughton

A case before the Court of Justice for the European Union threatens to radically redraw the patent landscape for embryonic stem cells. Ashley Roughton explains.

Myriad issues for gene patents

US01-05-2010

A recent US district court ruling could significantly affect companies that patent genes and threaten the health of an entire industry. LSIPR investigates.

What next for stem cell research?

EU01-05-2010

The European Court of Justice is faced with a crucial decision on stem cell research. Justin Turner QC explains.

Showing 641 to 650 of 654 results

LSIPR